Where Do I Inject My Mounjaro? A Comprehensive Guide to Injection Sites

Last reviewed: July 10, 2026

Last updated: July 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide is a dual GLP-1 and GIP receptor agonist administered once weekly via subcutaneous injection, and selecting appropriate injection sites directly impacts medication absorption and comfort. Proper site selection and rotation can minimize lipohypertrophy (fatty tissue buildup) and ensure consistent therapeutic outcomes. Understanding the anatomy of approved injection areas helps patients maximize the benefits of their compounded tirzepatide therapy.

Approved Tirzepatide Injection Sites for Weekly Dosing

Tirzepatide injections must be placed in the subcutaneous tissue—the fatty layer beneath the skin but above muscle. The FDA-approved injection sites include the abdomen, upper arm (back of the triceps area), and thigh. Each location has distinct advantages: the abdomen offers easy self-access and consistent absorption, the upper arm works well for those with limited abdominal tissue, and the thigh provides a stable platform for patients with dexterity concerns. PlexusDx patients receive detailed anatomical guidance during onboarding to ensure needle placement in the correct tissue layer.

The abdomen is the most commonly selected site because it provides reliable medication absorption and straightforward visualization during self-injection. Choose an area at least 2 inches away from the navel and avoid scars, moles, or areas with bruising. The upper thigh—from mid-thigh to just above the knee on the front or outer surface—offers an alternative when abdominal tissue is limited. The upper arm's back surface (triceps region) works well for weekly injections but may require assistance with proper needle angle.

How to Rotate Injection Sites to Prevent Tissue Damage

Site rotation is essential for patients on chronic tirzepatide therapy because repeated injections in the same location can trigger lipohypertrophy, a condition where fat tissue hardens or becomes lumpy. The recommended strategy involves using all approved sites in a planned sequence: select one abdominal quadrant (upper-left, upper-right, lower-left, lower-right) for the first injection, then move to the thigh, upper arm, and return to a different abdominal quadrant. This four-week rotation cycle gives each site adequate recovery time and maintains consistent drug absorption.

Within each anatomical region, maintain at least a 1-inch distance between injection points to avoid traumatizing the same tissue repeatedly. Many patients find it helpful to create a written schedule or use their smartphone calendar to track injection dates and locations. Rotating sites also helps identify which areas feel most comfortable for you personally—some patients prefer abdominal injections while others find the thigh less sensitive. PlexusDx recommends documenting your site rotation pattern during your first month to establish a sustainable routine.

Proper Injection Technique and Needle Insertion Depth

Tirzepatide is delivered via a short needle (typically 5-6mm) that penetrates only into subcutaneous fat, not muscle tissue. The correct injection angle is 90 degrees (straight in, perpendicular to the skin), which ensures the medication deposits in the adipose layer where it is absorbed systemically. Pinching the skin gently creates a fold that makes subcutaneous placement easier and reduces the risk of hitting muscle or underlying structures. After inserting the needle fully, pause for 3-5 seconds before releasing the plunger—this timing allows the needle bevel to stabilize within the tissue.

After injecting, leave the needle in place for 10 seconds to ensure complete medication delivery and to allow the tissue to redistribute evenly. Do not massage the injection site immediately afterward; gentle rubbing can cause the medication to leak back out and may increase bruising. Allow 15-30 minutes before applying pressure or touching the site. Patients should alternate which hand performs the injection when self-administering, and those with visual or mobility concerns can ask a family member or healthcare provider to assist.

Managing Common Injection Site Reactions and When to Seek Help

Mild redness, slight swelling, or minor bruising at the injection site is normal and usually resolves within 24-48 hours. Applying ice for 5-10 minutes before injection can numb the area and reduce discomfort, while a warm compress after injection can promote absorption and reduce post-injection soreness. Avoid injection sites with active bruising, open sores, or areas of hardened tissue (lipohypertrophy) until healing occurs. If you notice persistent swelling, warmth, increasing redness, or signs of infection (pus or fever), contact your PlexusDx care team immediately.

Lipohypertrophy appears as bumpy, firm, or thickened fatty tissue at frequently used injection sites and is entirely preventable through consistent site rotation. If you develop lipohypertrophy at any location, avoid injecting into that area for at least 4-6 weeks to allow the tissue to normalize. Rare but serious complications include nerve or blood vessel injury (which would cause severe sharp pain), but these are extremely uncommon when proper technique is followed. PlexusDx provides video guidance and telephone support to help patients refine their injection skills if site reactions occur.

Personalizing Your Injection Site Strategy with Precision Peptide Testing

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R (rs6923761), and GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Patients with genetic variants associated with slower adipose tissue absorption may benefit from specific injection site selection—for example, the abdomen often provides faster systemic absorption than the thigh. The Precision Peptide Genetic Test maps 14 peptide pathways and 49 peptides to provide insights into your individual drug response, allowing PlexusDx clinicians to personalize not just your medication choice and dose, but also practical administration details. This precision approach means your injection site strategy is tailored to your biology, not a one-size-fits-all recommendation.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject tirzepatide into the same spot every week, or must I rotate sites?

You must rotate injection sites to prevent lipohypertrophy (hardened fatty tissue), which can reduce medication absorption and cause discomfort. PlexusDx recommends using all approved sites (abdomen, thigh, upper arm) in a planned rotation cycle, spacing injections at least 1 inch apart within each region. Rotating sites every week ensures consistent drug delivery and maintains healthy tissue.

What is the difference between subcutaneous and intramuscular tirzepatide injection?

Tirzepatide must always be injected subcutaneously (into the fatty tissue layer), never intramuscularly. Subcutaneous injection allows the medication to absorb gradually into the bloodstream over hours, providing steady therapeutic levels throughout the week. Intramuscular injection would cause too-rapid absorption and is not recommended.

How much does PlexusDx compounded tirzepatide cost, and does the price change based on injection site or dose?

PlexusDx compounded tirzepatide injection starts at $289/mo (or $249/mo on the 6-month plan) flat—your dose may need to go up, but your price won't. The medication is available from licensed 503A compounding pharmacies, requires no insurance or membership, and is HSA/FSA eligible. All patients pay the same monthly rate regardless of their current dose level or injection site selection.

What should I do if I develop bruising, swelling, or redness at the injection site?

Mild bruising and redness within 24-48 hours are normal. Apply ice before injection to reduce discomfort and a warm compress afterward to promote absorption. Avoid injecting into bruised areas and maintain site rotation. If redness, swelling, or warmth persists beyond 48 hours or shows signs of infection (pus, fever), contact your PlexusDx care team immediately.

How does the PlexusDx Precision Peptide Genetic Test help with tirzepatide therapy?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Mounjaro Injection Sites
• Injection Mounjaro
• Mounjaro Injection Price
• Mounjaro Injection Site

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.